Myles Brown
Director, Center for Functional Cancer Epigenetics · Mass General Brigham
Credentials: · ·
History
- Present
Center for Functional Cancer Epigenetics · Mass General Brigham
Research
Model-based analysis of ChIP-Seq (MACS)
Genome biology · 2008 · 14,751 citations
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Nature Medicine · 2018 · 4,202 citations
Genome biology · 2014 · 2,165 citations
30 papers
- PK
28 papers
21 papers
17 papers
16 papers
- EL
11 papers
11 papers
- CS
9 papers
Grants
- 2013–2030
Androgen Receptor Action in Castration Resistant Prostate Cancer
National Cancer Institute · P01
Project lead · $4.8M · Beth Israel Deaconess Medical Center
- 2013–2030
Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer
National Cancer Institute · P50
Project lead · $1.5M · Dana-Farber Cancer Inst
- 2020–2026
New Therapeutic Vulnerabilities in Breast Cancer
National Cancer Institute · P01
Project lead · $1.7M · Dana-Farber Cancer Inst
- 2019–2024
Regulators of Cancer Immunotherapy Response
National Cancer Institute · R01
Contact PI · $1.2M · Dana-Farber Cancer Inst